Hospital & Home Clinical Authority

Evidence-Based Clinical Infusion Therapy Safety Protocols

An independent, peer-reviewed clinical knowledge base uniting oncology physicians, certified infusion nurses, and compounding pharmacists to eliminate preventable intravenous complications.

1. Bedside Emergency Decision Aids

Immediate bedside clinical assessment tools designed for acute decision support:

Interactive Diagnostic Triage

Infiltration vs. Extravasation Checker

Evaluate localized site swelling, pain, skin temperature, and drug category to determine INS staging and initiate emergency antidote protocols.

Bedside Safety Verification

7-Point Patient Safety Checklist

Patient and clinician verification checklist covering patient IDs, medication labels, smart pump rate guardrails, and fluid clarity.

2. Clinical Knowledge Pillars

Our clinical guidance is organized across 8 core topical pillars:

Pillar 1 · 10 Topics

Clinical Safety Standards

Extravasation antidotes, CDC CLABSI bundles, USP <800> CSTD, in-line filtration, sharps protection, and air embolism resuscitation.

Pillar 2 · 5 Therapies

High-Alert Therapies

IV iron formulation safety, IVIG rate titration schedules, Infliximab biologics, cytotoxic chemotherapy, and outpatient OPAT antibiotics.

Pillar 3 · Home Health

Home Infusion Care

PICC line sterile dressing and pulsatile flushing, Celsite® port Huber needle access, and caregiver emergency line clamping.

Pillar 4 · Decision Aids

Patient & Family Resources

Interactive symptom differential tool, 10 safety questions to ask care teams, and 7-point bedside checklists.

Pillar 5 · Accreditation

Provider Standards

INS 2024 Standards of Practice crosswalk, CDC catheter infection guidelines, and USP <797>/<800> sterile compounding rules.

Pillar 6 · E-E-A-T

Authority & Governance

Meet our multidisciplinary medical review board (CRNI, PharmD, MD Oncology) and review our GRADE evidence grading charter.

Pillar 7 · Inquiries

Clinical Consultations

Connect with our governance board for protocol inquiries, educational partnerships, or institutional guideline consultations.

Pillar 8 · Q&A

Clinical FAQ & Evidence Base

Direct answers to core clinical questions regarding vascular access maintenance, port septums, occlusion alarms, and BUD limits.

3. Clinical Governance & Review Board

Every clinical guide, dosage calculation, and safety algorithm on SafeInfusionTherapy.com is authored and verified by accredited practitioners:

  • Arthur Vance, MD, FACP: Board Certified Medical Oncologist with 22 years of clinical research experience in antineoplastic safety and vesicant extravasation antidotes.
  • Sarah Jenkins, MSN, RN, CRNI®, VA-BC™: Master of Science in Nursing with 18 years in hospital vascular access and home infusion leadership, specializing in INS standards compliance and CLABSI bundles.
  • Marcus Finch, PharmD, BCPPS, BCSCP: Board Certified Sterile Compounding Pharmacist directing hospital cleanroom operations and hazardous drug containment under USP <797>/<800>.

Review our complete Editorial Policy and Evidence Grading Methodology to examine our 12-month review cycle and commercial independence charter.

Clinical Practice Boundary Notice

This protocol provides evidence-based guidance reflecting INS 2024 Standards of Practice and CDC recommendations. Clinical judgment, institutional policy, and patient-specific variables must guide individualized bedside care.